Previous studies highlight the difficulty in predicting how perturbed Ca2+ binding in arrhythmia‐associated CaM variants translates to defective target modulation (Chazin & Johnson, 2020; Hussey et al., 2023; Jensen et al., 2018). The gene discussed is CALM3; the disease is cardiac arrhythmia.